Sioud M, Juzeniene A, Sæbøe-Larssen S(2024) Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens Vaccines (Basel), 12(6) DOI 10.3390/vaccines12060624, PubMed 38932353
Bobrowicz M, Kusowska A, Krawczyk M, Zhylko A, Forcados C, Slusarczyk A, Barankiewicz J, Domagala J, Kubacz M, Šmída M, Dostalova L, Marhelava K, Fidyt K, Pepek M, Baranowska I, Szumera-Cieckiewicz A, Inderberg EM, Wälchli S, Granica M, Graczyk-Jarzynka A, Majchrzak M, Poreba M, Gehlert CL, Peipp M, Firczuk Met al.(2024) CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies Oncoimmunology, 13(1), 2362454 DOI 10.1080/2162402X.2024.2362454, PubMed 38846084
Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S(2024) CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia Cell Rep Med, 5(6), 101572 DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420
